Beta
1.71
-0.04-2.29%
February 6, 2025
Summary
- As of February 7, 2025, the beta for ARDS stock is 1.71, with the most recent change of -0.04 (-2.29%) on February 6, 2025. This indicates that ARDS stock is more volatile than S&P 500 index
Performance
ARDS Beta Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
ARDS Beta Trends
PeriodPeriod | BetaBeta | PricePrice | SPXSPX |
---|---|---|---|
todaytoday | -2.3% | 0.0% | -0.9% |
1 m1 month | -14.9% | 0.0% | +2.0% |
3 m3 months | +14.0% | -50.0% | +1.0% |
6 m6 months | +643.5% | -90.0% | +16.0% |
ytdytd | -14.5% | 0.0% | +2.5% |
1 y1 year | +301.2% | -99.9% | +20.7% |
5 y5 years | +122.1% | -100.0% | +81.2% |
ARDS Beta Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 1.71 | at low | ||
3 m | 3-month | 2.25 | -24.0% | 1.50 | -12.3% |
6 m | 6-month | 2.25 | -24.0% | 0.17 | -90.1% |
1 y | 1-year | 2.25 | -24.0% | -1.20 | -170.2% |
3 y | 3-year | 2.25 | -24.0% | -1.34 | -178.4% |
5 y | 5-year | 2.25 | -24.0% | -1.34 | -178.4% |
alltime | all time | 2.25 | -24.0% | -1.34 | -178.4% |
Aridis Pharmaceuticals Stock Beta History
Date | Value |
---|---|
2025 | 1.71(-14.5%) |
2024 | 2.00(-256.3%) |
2023 | -1.28(-213.3%) |
2022 | 1.13(+88.3%) |
Date | Value |
---|---|
2021 | 0.60(+215.8%) |
2020 | 0.19(-71.6%) |
2019 | 0.67(+116.1%) |
2018 | 0.31 |
FAQ
- What is Aridis Pharmaceuticals beta?
- What is the all time high beta for Aridis Pharmaceuticals?
- What is ARDS beta year-to-date change?
- What is Aridis Pharmaceuticals beta year-on-year change?
What is Aridis Pharmaceuticals beta?
The current beta of ARDS is 1.71
What is the all time high beta for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high beta is 2.25
What is ARDS beta year-to-date change?
Aridis Pharmaceuticals beta has changed by -0.29 (-14.50%) since the beginning of the year
What is Aridis Pharmaceuticals beta year-on-year change?
Over the past year, ARDS beta has changed by +2.56 (+301.18%)